A 32-year-old man with schizophrenia has been on risperidone 6 mg daily for 8 months. He presents to the psychiatry clinic with complaints of progressive difficulty in maintaining erections and decreased libido for the past 3 months. On examination, he appears well-groomed and cooperative. Laboratory investigations reveal serum prolactin 85 ng/mL (normal <25 ng/mL). Testosterone is 250 ng/dL (normal 300–1000 ng/dL). What is the most appropriate next step in management?

Explanation

## Clinical Scenario Analysis This patient presents with **hyperprolactinemia-induced sexual dysfunction** secondary to risperidone, a typical antipsychotic with potent D~2~ dopamine receptor blockade in the tuberoinfundibular pathway. ### Pathophysiology of Antipsychotic-Induced Hyperprolactinemia **Key Point:** Dopamine is the physiologic prolactin-inhibiting factor (PIF). Antipsychotics that block D~2~ receptors in the hypothalamus remove this inhibition, leading to unopposed prolactin secretion. | Antipsychotic Class | Prolactin Risk | Mechanism | |---|---|---| | **Typical (1st gen)** | Very High | Potent D~2~ blockade | | **Risperidone** | High | D~2~ blockade + poor BBB selectivity | | **Paliperidone** | High | Active metabolite of risperidone | | **Amisulpride** | High | Selective D~2~/D~3~ antagonist | | **Aripiprazole** | Very Low | Partial D~2~ agonist (maintains dopamine tone) | | **Quetiapine** | Low | Weak D~2~ affinity | | **Clozapine** | Low | Minimal D~2~ blockade | ### Why Aripiprazole Is the Best Choice **High-Yield:** Aripiprazole is a **partial D~2~ agonist**, not a full antagonist. It maintains basal dopamine signaling in the tuberoinfundibular pathway, preventing prolactin elevation. This is the only antipsychotic that can **reduce** elevated prolactin levels. **Clinical Pearl:** Switching to aripiprazole is superior to: - Adding dopamine agonists (bromocriptine/cabergoline) — these require long-term use and have their own side effects - Dose reduction — may compromise psychotic symptom control - Adding sexual dysfunction agents — does not address the underlying hyperprolactinemia or its systemic effects (gynecomastia, osteoporosis risk, menstrual dysfunction in women) ### Expected Outcome Upon switching to aripiprazole: - Prolactin typically normalizes within 2–4 weeks - Sexual dysfunction resolves within 4–8 weeks - Testosterone levels recover - No loss of antipsychotic efficacy (aripiprazole is efficacious in schizophrenia) **Mnemonic:** **ARIA** = **Aripiprazole Reduces Inappropriate Antipsychotic-prolactin Elevation [cite:Stahl's Essential Psychopharmacology Ch 5]